The consequences of Nrf2 activation in immune cells including macrophages is highly context-dependent, and although Nrf2 activation in macrophages that have not been exposed to the cancer secretome has anti-inflammatory outcomes [30,65,66], the effects of Nrf2 activation on macrophages within the specific context of lung cancer has not been sufficiently investigated. The gene discussed is NFE2L2; the disease is cancer.